189 “Clinical benefit response” (CBR) using cisplatin and gemcitabine in patients (pts) with advanced non-small cell lung cancer (ANSCLC)

✍ Scribed by Monterubbianesi, M.C.; Mari, D.; Lippe, P.; Tummarello, D.

• Book ID: 123498524
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 148 KB
• Volume: 18
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(97)89467-6